Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?

Clinical trial NCT05895643 · COMPLETED

Trial details

NCT number: NCT05895643
Sponsor: Psychiatric Centre Rigshospitalet
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Abuse Alcohol Addiction Alcohol Dependence Alcohol Use Disorder

Start date: 2023-06-13
Primary completion: 2025-07-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.